Skip to Content

Synjardy

In the US, Synjardy (empagliflozin/metformin systemic) is a member of the drug class antidiabetic combinations and is used to treat Diabetes, Type 2.

US matches:

UK matches:

Ingredient matches for Synjardy

Empagliflozin

Empagliflozin is reported as an ingredient of Synjardy in the following countries:

  • Germany
  • Slovenia
  • United Kingdom
  • United States

Metformin

Metformin is reported as an ingredient of Synjardy in the following countries:

  • Slovenia

Metformin hydrochloride (a derivative of Metformin) is reported as an ingredient of Synjardy in the following countries:

  • Germany
  • United Kingdom
  • United States

International Drug Name Search

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide